27 related articles for article (PubMed ID: 16492584)
1. Inositol and antioxidant supplementation: Safety and efficacy in pregnancy.
Formoso G; Baldassarre MPA; Ginestra F; Carlucci MA; Bucci I; Consoli A
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3154. PubMed ID: 30889626
[TBL] [Abstract][Full Text] [Related]
2. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia.
Paine MA; Scioscia M; Gumaa KA; Rodeck CH; Rademacher TW
J Reprod Immunol; 2006 Apr; 69(2):165-79. PubMed ID: 16384607
[TBL] [Abstract][Full Text] [Related]
3. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels.
Kunjara S; Greenbaum AL; Wang DY; Caro HN; McLean P; Redman CW; Rademacher TW
Mol Genet Metab; 2000 Feb; 69(2):144-58. PubMed ID: 10720442
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus.
Scioscia M; Kunjara S; Gumaa K; McLean P; Rodeck CH; Rademacher TW
Diabet Med; 2007 Nov; 24(11):1300-4. PubMed ID: 17956457
[TBL] [Abstract][Full Text] [Related]
5. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension.
Scioscia M; Paine MA; Gumaa K; Rodeck CH; Rademacher TW
J Matern Fetal Neonatal Med; 2008 Aug; 21(8):581-5. PubMed ID: 18609357
[TBL] [Abstract][Full Text] [Related]
6. Inositol phosphoglycan putative insulin mediator in human amniotic fluid.
Scioscia M; Vimercati A; Selvaggi LE; Rodeck CH; Rademacher TW
J Matern Fetal Neonatal Med; 2006 Jan; 19(1):9-12. PubMed ID: 16492584
[TBL] [Abstract][Full Text] [Related]
7. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies.
Scioscia M; Gumaa K; Whitten M; Selvaggi LE; Rodeck CH; Rademacher TW
J Reprod Immunol; 2007 Dec; 76(1-2):85-90. PubMed ID: 17493685
[TBL] [Abstract][Full Text] [Related]
8. Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?
Rademacher TW; Gumaa K; Scioscia M
J Reprod Immunol; 2007 Dec; 76(1-2):78-84. PubMed ID: 17537518
[TBL] [Abstract][Full Text] [Related]
9. Inositol phosphoglycans and preeclampsia: from bench to bedside.
Scioscia M; Williams PJ; Gumaa K; Fratelli N; Zorzi C; Rademacher TW
J Reprod Immunol; 2011 May; 89(2):173-7. PubMed ID: 21549431
[TBL] [Abstract][Full Text] [Related]
10. Endometrial secretions: creating a stimulatory microenvironment within the human early placenta and implications for the aetiopathogenesis of preeclampsia.
Burton GJ; Scioscia M; Rademacher TW
J Reprod Immunol; 2011 May; 89(2):118-25. PubMed ID: 21531028
[TBL] [Abstract][Full Text] [Related]
11. Maternal antenatal anxiety and amniotic fluid cortisol and testosterone: possible implications for foetal programming.
Sarkar P; Bergman K; O'Connor TG; Glover V
J Neuroendocrinol; 2008 Apr; 20(4):489-96. PubMed ID: 18266948
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
